Perspective Therapeutics Updates Corporate Presentation
Perspective Therapeutics updated its corporate presentation, highlighting clinical progress and ASCO 2026 data for its 212Pb-based radiopharmaceutical pipeline.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Inventiva H1 2026 Earnings Call: Complete Transcript
On Monday, Inventiva (NASDAQ: IVA ) discussed quarterly financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Inventiva reported a strong financial position w
Perspective Therapeutics updates presentation on 212Pb pipeline
Perspective Therapeutics updated its corporate presentation to highlight progress across three clinical-stage 212Pb radiopharmaceutical programs and a combined $45B+ solid tumor market opportunity.